Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.071 | 0.7 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.07 | 0.7 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |